TY  - GEN
AU  - Ten Berg,Jurrien M
AU  - Steg,Philippe Gabriel
AU  - Bhatt,Deepak L
AU  - Hohnloser,Stefan H
AU  - de Veer,Anne
AU  - Nordaby,Matias
AU  - Miede,Corinna
AU  - Kimura,Takeshi
AU  - Lip,Gregory Y H
AU  - Oldgren,Jonas
AU  - Cannon,Christopher P
TI  - Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)
SN  - 1879-1913
PY  - 2020///0629
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Anticoagulants
KW  - therapeutic use
KW  - Aspirin
KW  - Atrial Fibrillation
KW  - complications
KW  - Clopidogrel
KW  - Coronary Artery Disease
KW  - therapy
KW  - Dabigatran
KW  - Drug Therapy, Combination
KW  - Female
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myocardial Revascularization
KW  - statistics & numerical data
KW  - Percutaneous Coronary Intervention
KW  - Platelet Aggregation Inhibitors
KW  - Proportional Hazards Models
KW  - Stroke
KW  - etiology
KW  - Thromboembolism
KW  - epidemiology
KW  - Ticagrelor
KW  - Treatment Outcome
KW  - Warfarin
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.amjcard.2019.11.029
ER  -